Health Catalyst (NASDAQ:HCAT) Releases Earnings Results, Misses Estimates By $0.03 EPS

Health Catalyst (NASDAQ:HCAT) announced its earnings results on Wednesday. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.03), Briefing.com reports. Health Catalyst had a negative net margin of 26.20% and a negative return on equity of 7.49%. The firm had revenue of $76.40 million during the quarter, compared to analyst estimates of $76.27 million. During the same quarter last year, the business earned ($0.22) earnings per share. Health Catalyst’s revenue was up 3.5% on a year-over-year basis. Health Catalyst updated its FY 2024 guidance to EPS and its Q4 2024 guidance to EPS.

Health Catalyst Trading Down 7.0 %

Health Catalyst stock traded down $0.62 during mid-day trading on Friday, hitting $8.24. The company had a trading volume of 674,743 shares, compared to its average volume of 485,899. Health Catalyst has a 12-month low of $5.42 and a 12-month high of $11.41. The company’s fifty day moving average is $8.07 and its 200-day moving average is $7.14.

Insider Activity

In other Health Catalyst news, COO Daniel Lesueur sold 5,209 shares of the company’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $7.70, for a total value of $40,109.30. Following the completion of the transaction, the chief operating officer now owns 129,690 shares in the company, valued at approximately $998,613. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, insider Kevin Lee Freeman sold 7,500 shares of the business’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.22, for a total value of $54,150.00. Following the completion of the sale, the insider now owns 255,881 shares of the company’s stock, valued at approximately $1,847,460.82. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Daniel Lesueur sold 5,209 shares of the stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $7.70, for a total transaction of $40,109.30. Following the transaction, the chief operating officer now directly owns 129,690 shares in the company, valued at approximately $998,613. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 35,396 shares of company stock valued at $266,280 in the last three months. 2.50% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

HCAT has been the subject of several recent analyst reports. Stephens lowered their price target on Health Catalyst from $8.00 to $7.00 and set an “equal weight” rating for the company in a report on Thursday, August 8th. Evercore ISI boosted their target price on shares of Health Catalyst from $8.00 to $10.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. JPMorgan Chase & Co. upped their price target on shares of Health Catalyst from $10.00 to $13.00 and gave the company an “overweight” rating in a research note on Wednesday, September 4th. Cantor Fitzgerald restated an “overweight” rating and issued a $16.00 target price on shares of Health Catalyst in a research note on Friday, October 4th. Finally, Piper Sandler dropped their price target on Health Catalyst from $14.00 to $11.00 and set an “overweight” rating on the stock in a research note on Monday, August 26th. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $11.64.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.